Darlifarnib
(14R)-14-amino-14-(3-methylimidazol-4-yl)-7-oxa-19-azapentacyclo[13.6.2.12,6.19,13.018,22]pentacosa-1(22),2(25),3,5,9,11,13(24),15(23),16,18,20-undecaene-10,20-dicarbonitrile
Molecular Identity
Darlifarnib
(14R)-14-amino-14-(3-methylimidazol-4-yl)-7-oxa-19-azapentacyclo[13.6.2.12,6.19,13.018,22]pentacosa-1(22),2(25),3,5,9,11,13(24),15(23),16,18,20-undecaene-10,20-dicarbonitrile
PubChem CID: 169292214
2D Structure
Properties
C29H20N6O
Molecular Formula
468.50
Molecular Weight
g/mol
468.1699
Exact Mass
Da
3.3
XLogP
Drug-like (Lipinski: < 5)
114
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
6
H-Bond Acceptors
908
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(6)
Darlifarnibdarlifarnib [INN]9PE5MSX2YSSCHEMBL26565609(3S)-3-amino-3-(1-methyl-1H-imidazol-5-yl)-6-oxa-2(4,6)-quinolina-1,4(1,3)-dibenzenacyclohexaphane-22,44-dicarbonitrile3065226-39-0
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Darlifarnib
Loading drug network...